September 27, 2010 – Raleigh, NC – Athena GTX®, a developer of innovative trauma care products, has received clearance from the U.S. Food and Drug Administration (FDA) for the WVSM™ device, its new compact, patient-worn vital signs monitor.
Originally developed for the U.S. military, the WVSM™ is an innovative device that automatically measures blood pressure, pulse rate, blood oxygenation, and critical cardiac functions from point of injury through transport to a treatment center. Feedback from military testing revealed that early monitoring, trending, and recording of vital signs improve the survival rates of soldiers.